CA-125 as a response marker for vintafolide + pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer: The PRECEDENT trial
| Autor: | Bidzinski, M., Lovejoy, C., Anderson, K., Rangwala, R., Kutarska, E. |
|---|---|
| Zdroj: | In Gynecologic Oncology June 2014 133 Supplement 1:177-178 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect